Skip to content
2000
Volume 4, Issue 2
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882

Abstract

Background

S100B, NSE, MMP-9, and Tau protein levels increase in cases causing hypoxic cell damage. The diagnosis of the severity of carbon monoxide (CO) poisoning in the early period of these parameters was studied.

Materials and Methods

COHb level measurement was made using a signal capture CO-pulse oximeter (Masimo's SET Rainbow, Masimo's Co, USA) at the first admission of the patients. Then, COHb levels were confirmed by arterial blood gas(ABG) analysis. The patients were divided into two groups as mild and moderate-severe, according to their Glasgow coma scores (GCS) [Mild (14–15); Moderate (9–13) or Severe (3–8)]. The control group was composed of 16 healthy and non-smoking volunteers.

Results

The serum S100B protein and MMP-9 values at 0 hr of admission in the hospital and 3hr of treatment were not significantly different in the patient group as compared to the control group. Tau protein levels were significantly higher in the patient group at 0 and 3 hours (p> 0.05) as compared to healthy person.

Conclusion

There was no relationship between CO poisoning and MMP-9 and S100B protein levels. NSE and Tau protein were significantly higher in the patient group than the control group. Tau protein may be more useful marker as compared to neuron-specific enolase.

© 2023 The Author(s). Published by Bentham Science Publisher. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0250688204666230508115135
2023-07-18
2025-03-01
The full text of this item is not currently available.

References

  1. GüzelM. AtayE. TerziÖ. DemirM. ErenlerA. DemirM. The role of lactate and troponin-I levels in predicting length of hospital stay in patients with carbon monoxide poisoning.Clin. Lab.201965(5).10.7754/Clin.Lab.2018.18092931115207
    [Google Scholar]
  2. HampsonN.B. Trends in the incidence of carbon monoxide poisoning in the United States.Am. J. Emerg. Med.200523783884110.1016/j.ajem.2005.03.01416291437
    [Google Scholar]
  3. OmayeS.T. Metabolic modulation of carbon monoxide toxicity.Toxicology2002180213915010.1016/S0300‑483X(02)00387‑612324190
    [Google Scholar]
  4. HopperC.P. De La CruzL.K. LylesK.V. WarehamL.K. GilbertJ.A. EichenbaumZ. MagierowskiM. PooleR.K. WollbornJ. WangB. Role of Carbon Monoxide in Host–Gut Microbiome Communication.Chem. Rev.202012024132731331110.1021/acs.chemrev.0c0058633089988
    [Google Scholar]
  5. WrightJ. Chronic and occult carbon monoxide poisoning: we don’t know what we’re missing.Emerg. Med. J.200219538639010.1136/emj.19.5.38612204981
    [Google Scholar]
  6. KavakN. DoğanB. SultanoğluH. KavakR.P. Özdemi̇rM. Clinical and magnetic resonance imaging findings of patients with acute carbon monoxide poisoning.Konuralp Tip Derg.202012344345010.18521/ktd.735274
    [Google Scholar]
  7. KaoL.W. NañagasK.A. Carbon monoxide poisoning.Emerg. Med. Clin. North Am.2004224985101810.1016/j.emc.2004.05.00315474779
    [Google Scholar]
  8. OliverioS. VarletV. What are the limitations of methods to measure carbon monoxide in biological samples?Forensic Toxicol.202038111410.1007/s11419‑019‑00490‑1
    [Google Scholar]
  9. AdamiC. SorciG. BlasiE. AgnelettiA.L. BistoniF. DonatoR. S100b expression in and effects on microglia.Glia200133213114210.1002/1098‑1136(200102)33:2<131::AID‑GLIA1012>3.0.CO;2‑D11180510
    [Google Scholar]
  10. BrvarM. MožinaH. OsredkarJ. MožinaM. NočM. BručanA. BuncM. S100B protein in carbon monoxide poisoning: a pilot study.Resuscitation200461335736010.1016/j.resuscitation.2004.01.00915172716
    [Google Scholar]
  11. RasmussenL.S. PoulsenM.G. ChristiansenM. JansenE.C. Biochemical markers for brain damage after carbon monoxide poisoning.Acta Anaesthesiol. Scand.200448446947310.1111/j.1399‑6576.2004.00362.x15025610
    [Google Scholar]
  12. CakirZ. AslanS. UmudumZ. AcemogluH. AkozA. TurkyılmazS. ÖztürkN. S-100β and neuron-specific enolase levels in carbon monoxide–related brain injury.Am. J. Emerg. Med.2010281616710.1016/j.ajem.2008.10.03220006203
    [Google Scholar]
  13. YardanT. CevikY. DondericiO. KavalciC. YilmazF.M. YilmazG. VuralK. YuzbasiogluY. GunaydinY.K. SezerA.A. Elevated serum S100B protein and neuron-specific enolase levels in carbon monoxide poisoning.Am. J. Emerg. Med.200927783884210.1016/j.ajem.2008.04.01619683113
    [Google Scholar]
  14. AkdemirH.U. YardanT. KatiC. DuranL. AlacamH. YavuzY. OkuyucuA. The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning.Hum. Exp. Toxicol.201433111113112010.1177/096032711452104924505052
    [Google Scholar]
  15. BrvarM. MožinaH. OsredkarJ. MožinaM. BručanA. BuncM. The potential value of the protein S-100B level as a criterion for hyperbaric oxygen treatment and prognostic marker in carbon monoxide poisoned patients.Resuscitation200356110510910.1016/S0300‑9572(02)00289‑712505746
    [Google Scholar]
  16. GawlikowskiT. GolasikM. GomółkaE. PiekoszewskiW. Proteins as biomarkers of carbon monoxide neurotoxicity.Inhal. Toxicol.2014261488589010.3109/08958378.2014.97078625357234
    [Google Scholar]
  17. JohnssonP. BlomquistS. LührsC. MalmkvistG. AllingC. SolemJ.O. StåhlE. Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation.Ann. Thorac. Surg.200069375075410.1016/S0003‑4975(99)01393‑410750755
    [Google Scholar]
  18. AmeriM. ShabaninejadZ. MovahedpourA. SahebkarA. MohammadiS. HosseindoostS. EbrahimiM.S. SavardashtakiA. KarimipourM. MirzaeiH. Biosensors for detection of Tau protein as an Alzheimer’s disease marker.Int. J. Biol. Macromol.20201621100110810.1016/j.ijbiomac.2020.06.23932603732
    [Google Scholar]
  19. HesseC. RosengrenL. AndreasenN. DavidssonP. VandersticheleH. VanmechelenE. BlennowK. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke.Neurosci. Lett.2001297318719010.1016/S0304‑3940(00)01697‑911137759
    [Google Scholar]
  20. MontanerJ. Alvarez-SabínJ. MolinaC. AnglésA. AbilleiraS. ArenillasJ. GonzálezM.A. MonasterioJ. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment.Stroke20013281759176610.1161/01.STR.32.8.175911486102
    [Google Scholar]
  21. Alvarez-SabínJ. DelgadoP. AbilleiraS. MolinaC.A. ArenillasJ. RibóM. SantamarinaE. QuintanaM. MonasterioJ. MontanerJ. Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome.Stroke20043561316132210.1161/01.STR.0000126827.69286.9015087562
    [Google Scholar]
  22. AkelmaA.Z. CelikA. OzdemirO. Kavak AkelmaF. AbaciA. RaziC.H. KislalF.M. AkinO. Neuron-specific enolase and S100B protein in children with carbon monoxide poisoning: children are not just small adults.Am. J. Emerg. Med.201331352452810.1016/j.ajem.2012.10.00923380091
    [Google Scholar]
  23. MenaJ.H. SanchezA.I. RubianoA.M. PeitzmanA.B. SperryJ.L. GutierrezM.I. PuyanaJ.C. Effect of the modified Glasgow Coma Scale score criteria for mild traumatic brain injury on mortality prediction: comparing classic and modified Glasgow Coma Scale score model scores of 13.J. Trauma20117151185119310.1097/TA.0b013e31823321f822071923
    [Google Scholar]
  24. LeiteM.C. GallandF. BroleseG. GuerraM.C. BortolottoJ.W. FreitasR. AlmeidaL.M.V. GottfriedC. GonçalvesC.A. A simple, sensitive and widely applicable ELISA for S100B: Methodological features of the measurement of this glial protein.J. Neurosci. Methods20081691939910.1016/j.jneumeth.2007.11.02118178255
    [Google Scholar]
  25. XueL. WangW.L. LiY. GongX. BaoJ.X. ZhangH.J. XieX.P. ChangY.M. LiJ.S. Effects of hyperbaric oxygen on hippocampal neuronal apoptosis in rats with acute carbon monoxide poisoning.Undersea Hyperb. Med.201744212113110.22462/3.4.2017.528777902
    [Google Scholar]
  26. LakhanS.E. KirchgessnerA. TepperD. LeonardA. Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.Front. Neurol.201343210.3389/fneur.2013.0003223565108
    [Google Scholar]
  27. MontanerJ. MolinaC.A. MonasterioJ. AbilleiraS. ArenillasJ.F. RibóM. QuintanaM. Alvarez-SabínJ. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.Circulation2003107459860310.1161/01.CIR.0000046451.38849.9012566373
    [Google Scholar]
  28. VukasovicI. Tesija-KunaA. TopicE. SupancV. DemarinV. PetrovcicM. Matrix metalloproteinases and their inhibitors in different acute stroke subtypes.Clin. Chem. Lab. Med.200644442843410.1515/CCLM.2006.07916599837
    [Google Scholar]
  29. ZhongC. YangJ. XuT. XuT. PengY. WangA. WangJ. PengH. LiQ. JuZ. GengD. ZhangY. HeJ. Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke.Neurology201789880581210.1212/WNL.000000000000425728747453
    [Google Scholar]
  30. AbdelnaseerM.M. ElfauomyN.M. EsmailE.H. KamalM.M. ElsawyE.H. Matrix metalloproteinase-9 and recovery of acute ischemic stroke.J. Stroke Cerebrovasc. Dis.201726473374010.1016/j.jstrokecerebrovasdis.2016.09.04328063771
    [Google Scholar]
  31. IshidaH. MurataN. TadaM. OkadaN. HashimotoD. KubotaS. ShirakawaK. WakasugiH. Determining the levels of matrix metalloproteinase-9 in portal and peripheral blood is useful for predicting liver metastasis of colorectal cancer.Jpn. J. Clin. Oncol.200333418619110.1093/jjco/hyg03512810833
    [Google Scholar]
  32. IizasaT. FujisawaT. SuzukiM. MotohashiS. YasufukuK. YasukawaT. BabaM. ShibaM. Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.Clin. Cancer Res.1999511491539918213
    [Google Scholar]
  33. CheB. ZhongC. GeJ. LiR. ZhuZ. BuX. XuT. JuZ. LiuJ. ZhangJ. ChenJ. ZhangY. HeJ. Serum matrix metalloproteinase-9 is associated with depression after acute ischemic stroke.Circ. J.201983112303231110.1253/circj.CJ‑19‑037631564697
    [Google Scholar]
  34. BaudierJ. GentilB.J. The S100B Protein and Partners in Adipocyte Response to Cold Stress and Adaptive Thermogenesis: Facts, Hypotheses, and Perspectives.Biomolecules202010684310.3390/biom1006084332486507
    [Google Scholar]
  35. CiccarelliR. Di IorioP. BrunoV. BattagliaG. D’AlimonteI. D’OnofrioM. NicolettiF. CaciagliF. Activation of A1 adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100? protein from cultured astrocytes.Glia199927327528110.1002/(SICI)1098‑1136(199909)27:3<275::AID‑GLIA9>3.0.CO;2‑010457374
    [Google Scholar]
  36. PintoS.S. GottfriedC. MendezA. GonçalvesD. KarlJ. GonçalvesC.A. WofchukS. RodnightR. Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology.FEBS Lett.2000486320320710.1016/S0014‑5793(00)02301‑211119704
    [Google Scholar]
  37. DonatoR. Intracellular and extracellular roles of S100 proteins.Microsc. Res. Tech.200360654055110.1002/jemt.1029612645002
    [Google Scholar]
  38. HerrmannM. VosP. WunderlichM.T. de BruijnC.H.M.M. LamersK.J.B. Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein.Stroke200031112670267710.1161/01.STR.31.11.267011062293
    [Google Scholar]
  39. FoerchC. NiessnerM. BackT. BauerleM. De MarchisG.M. FerbertA. GrehlH. HamannG.F. JacobsA. KastrupA. KlimpeS. PalmF. ThomallaG. WorthmannH. SitzerM. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke.Clin. Chem.201258123724510.1373/clinchem.2011.17267622125303
    [Google Scholar]
  40. WunderlichM.T. LinsH. SkalejM. WalleschC.W. GoertlerM. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke.Clin. Neurol. Neurosurg.2006108655856310.1016/j.clineuro.2005.12.00616457947
    [Google Scholar]
  41. LiL. LiJ. ChaiC.G. ZhangJ.J. ZhangS.Y. [Application value of BIS and S100β combined with Copeptin in patients with acute severe carbon monoxide poisoning].Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi202240320420835439863
    [Google Scholar]
  42. IrazuztaJ.E. de Courten-MyersG. ZemlanF.P. BekkedalM.Y.V. RossiJ.III Serum cleaved Tau protein and neurobehavioral battery of tests as markers of brain injury in experimental bacterial meningitis.Brain Res.200191319510510.1016/S0006‑8993(01)02764‑011532253
    [Google Scholar]
  43. KilicaslanI. BildikF. AkselG. YavuzG. GulbaharO. KelesA. DemircanA. Serum tau protein level for neurological injuries in carbon monoxide poisoning.Clin. Toxicol. (Phila.)201250649750210.3109/15563650.2012.69874222746384
    [Google Scholar]
/content/journals/nemj/10.2174/0250688204666230508115135
Loading
/content/journals/nemj/10.2174/0250688204666230508115135
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test